Want to join the conversation?
$PFE raised its 2015 adjusted net income forecast to $2.16-2.20 a share, up from the $2.04-2.10 a share the company guided to in Sept. 2015 after completing the Hospira acquisition. Revenue is expected to be between $47.5-48.5Bil, up from $46.5-47.5Bil previously announced.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)